DOI:
10.1055/s-00000181
Journal of Neurological Surgery Part B: Skull Base
LinksClose Window
References
Esmaeli B, McLaughlin P, Pro B. et al.
Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma.
Ann Oncol 2009;
20 (04) 709-714
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.